Back
ESC Premium Access

Myocardial fibrosis predicts adverse outcome after percutaneous mitral valve repair

Session: Poster session 2 - Mitral Valve Interventions
Topic: Mitral valve interventions
Speaker: Ms J. Velu (Amsterdam, NL)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Ms Juliette Francine Velu

Academic Medical Centre, Amsterdam (Netherlands (The))
0 follower

11 more presentations in this session

MitraClip implantation as effective symptomatic therapy of dynamic mitral regurgitation unraveled by handgrip echocardiography.

Speaker: Associate Professor M. Spieker (Duesseldorf, DE)

Access
Abstract
Slides
Like
Thumbnail

Echocardiographic predictors for a single vs. multiclip strategy in percutaneous mitral valve repair

Speaker: Doctor B. Goebel (Bad Berka, DE)

Access
Abstract
Like
Thumbnail

In patients with end stage functional mitral regurgitation, mitral annulus geometry is independent on the ischemic or non-ischemic etiology of left ventricular dysfunction

Speaker: Doctor N. Ruozi (Reggio Nell'Emilia, IT)

Access
Abstract
Slides
Like
Thumbnail

Spherical ventricle, large left atrium size and anemia predict 1-year failure of MitraClip therapy in patients with functional mitral regurgitation

Speaker: Doctor K. Hellhammer (Duesseldorf, DE)

Access
Abstract
Like
Thumbnail

Impact of post-procedural mitral stenosis on long-term outcome in high-surgical risk patients treated successfully by MitraClip implantation

Speaker: Doctor D. Kalbacher (Hamburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster session 2 - Mitral Valve Interventions

Speakers: Ms J. Velu, Associate Professor M. Spieker, Doctor B. Goebel, Doctor N. Ruozi, Doctor K. Hellhammer...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources